Patients with hereditary angioedema receiving C1 inhibitor (human) for the treatment or prevention of angioedema attacks in routine clinical practice

被引:0
|
作者
Saguer, I. Martinez [1 ]
Grumach, A. S. [2 ]
Aygoeren-Puersuen, E. [3 ]
Andresen, I. [4 ]
Botha, J. [4 ]
Wietek, S. [5 ]
机构
[1] HZRM Hemophilia Ctr Rhine Main, Morfelden Walldorf, Germany
[2] Ctr Univ FMABC, Santo Andre, SP, Brazil
[3] Goethe Univ, Univ Hosp Frankfurt, Frankfurt, Germany
[4] Takeda Pharmaceut Int AG, Zurich, Switzerland
[5] Baxalta Innovat GmbH, Vienna, Austria
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
000901
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy
    Hakl, Roman
    Kuklinek, Pavel
    Krcmova, Irena
    Kralickova, Pavlina
    Freiberger, Tomas
    Janku, Petr
    Vlkova, Marcela
    Litzman, Jiri
    JOURNAL OF CLINICAL IMMUNOLOGY, 2018, 38 (07) : 810 - 815
  • [32] Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry
    Valerieva, Anna
    Staevska, Maria T.
    Grivcheva-Panovska, Vesna
    Jesenak, Milos
    Kohalmi, Kinga Viktoria
    Hrubiskova, Katarina
    Zanichelli, Andrea
    Bellizzi, Luca
    Relan, Anurag
    Hakl, Roman
    Farkas, Henriette
    WORLD ALLERGY ORGANIZATION JOURNAL, 2021, 14 (04):
  • [33] Nanofiltered C1 esterase inhibitor (human) for hereditary angioedema attacks in pregnant women
    Baker, James W.
    Craig, Timothy J.
    Riedl, Marc A.
    Banerji, Aleena
    Fitts, David
    Kalfus, Ira N.
    Uknis, Marc E.
    ALLERGY AND ASTHMA PROCEEDINGS, 2013, 34 (02) : 162 - 169
  • [34] Use of nanofiltered C1 esterase inhibitor (human) for the treatment of gastrointestinal attacks in subjects with hereditary angioedema
    Lumry, W.
    Baker, J.
    Levy, R.
    Hurewitz, D.
    White, M.
    Craig, T.
    Riedl, M.
    Busse, P.
    Grant, A.
    Mariano, D.
    Kalfus, I
    ALLERGY, 2011, 66 : 418 - 419
  • [35] Sustained response of recombinant human C1 esterase inhibitor for acute treatment of hereditary angioedema attacks
    Bernstein, Jonathan A.
    Relan, Anurag
    Harper, Joseph R.
    Riedl, Marc
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 118 (04) : 452 - 455
  • [36] Recombinant human C1 esterase inhibitor for acute treatment of hereditary angioedema attacks: a european registry
    Valerieva, A.
    Staevska, M.
    Grivcheva-Panovska, V
    Jesenak, M.
    Viktoria, Kohalmi K.
    Hrubiskova, K.
    Zanichelli, A.
    Bellizzi, L.
    Relan, A.
    Hakl, R.
    Farkas, H.
    ALLERGY, 2021, 76 : 367 - 368
  • [37] Clinical Outcomes With Recombinant Human C1 Inhibitor In The Repeat Treatment Of Acute Attacks Of Hereditary Angioedema In North-american Patients
    Zuraw, B.
    Craig, T.
    Lockey, R. F.
    Park, M.
    Grant, J.
    Suez, D.
    Schwartz, L. B.
    Riedl, M.
    Levy, R. J.
    Li, H. H.
    Edara, L.
    Bernstein, J. A.
    Moy, J.
    Offenberger, J.
    Szema, A.
    Engler, A.
    Rehman, S. M.
    Marbury, T. C.
    Alpan, O.
    Bahna, S. L.
    Davis, A.
    Sussman, G.
    Yang, W. H.
    Ritchie, B.
    Relan, A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB101 - AB101
  • [38] Turkish patients' perception about the C1 inhibitor concentrate in the treatment of the acute attacks of hereditary angioedema
    Demir, S.
    Olgac, M.
    Coskun, R.
    Unal, D.
    Gelincik, A.
    Gulec, M.
    Colakoglu, B.
    Buyukozturk, S.
    ALLERGY, 2017, 72 : 711 - 711
  • [39] Clinical studies of recombinant human C1 inhibitor (rhC1INH) in patients with acute attacks of hereditary angioedema
    Nuijens, J.
    Verdonk, R.
    Giannetti, B.
    Visscher, S.
    van Doorn, M.
    Resink, T.
    Levi, M.
    Hack, C.
    Farkas, H.
    Obtulowicz, K.
    Caballero, T.
    Cicardi, M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (03) : 797 - 797
  • [40] C1 Inhibitor Therapy and Hereditary Angioedema
    Kalfus, Ira
    Frank, Michael
    AMERICAN JOURNAL OF MEDICINE, 2010, 123 (04): : E15 - E15